What is the potential of psilocin?
This week, the University of California at San Francisco's (UCF) Translational Psychedelic Research Program and psychedelic drug development company Filament were given FDA approval for their first-ever clinical trial to test psilocin. This is the molecule that results from your body metabolizing psilocybin, the main psycho-active substance in magic mushrooms.
Filament recently announced that it has developed a way to extract psilocin, which can lead to faster-acting treatments and fewer side effects. The first trial will involve 20 people. They'll report back their experiences in two months time so we might learn more then!